Margaret McLoughlin - Aug 8, 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Brendan Hannah, Attorney-in-Fact for Margaret McLoughlin
Stock symbol
QNCX
Transactions as of
Aug 8, 2023
Transactions value $
$9,840
Form type
4
Date filed
8/9/2023, 06:18 PM
Previous filing
May 26, 2023
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Purchase $9.84K +8K $1.23 8K Aug 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.